Literature DB >> 4127872

Lysolecithin binding to human and squirrel monkey plasma and tissue components.

O W Portman, D R Illingworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4127872     DOI： 10.1016/0005-2760(73)90025-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  8 in total

1.  Cultivation of HeLa cells with fetal bovine serum or Ultroser G: effects on the plasma membrane constitution.

Authors:  Y Blixt; A Valeur; E Everitt
Journal:  In Vitro Cell Dev Biol       Date:  1990-07

2.  Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel.

Authors:  Xiangdong Zhu; Jonathan Learoyd; Sanober Butt; Lilly Zhu; Peter V Usatyuk; Viswanathan Natarajan; Nilda M Munoz; Alan R Leff
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-11       Impact factor: 6.914

3.  Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein.

Authors:  G Murugesan; P L Fox
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Characterization of plasma unsaturated lysophosphatidylcholines in human and rat.

Authors:  M Croset; N Brossard; A Polette; M Lagarde
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

5.  Albumin stimulates the release of lysophosphatidylcholine from cultured rat hepatocytes.

Authors:  D J Baisted; B S Robinson; D E Vance
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

6.  Metabolism of lysophosphatidylcholine by swine platelets.

Authors:  D E Chen; A A White; M E Tumbleson; G Y Sun
Journal:  Lipids       Date:  1985-03       Impact factor: 1.880

7.  Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.

Authors:  Kirsi H Pietiläinen; Marko Sysi-Aho; Aila Rissanen; Tuulikki Seppänen-Laakso; Hannele Yki-Järvinen; Jaakko Kaprio; Matej Oresic
Journal:  PLoS One       Date:  2007-02-14       Impact factor: 3.240

8.  Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties.

Authors:  Timothy J Cunningham; Lihua Yao; Angel Lucena
Journal:  J Inflamm (Lond)       Date:  2008-10-22       Impact factor: 4.981
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.